Pharmacotherapy for treatment-resistant schizophrenia
Meghan E Mcilwain1,2, Jeff Harrison1, Amanda J Wheeler1,3, Bruce R Russell1,21School of Pharmacy, Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand; 2Centre for Brain Research, Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand;...
Saved in:
Main Authors: | Meghan E Mcilwain, Jeff Harrison, Amanda J Wheeler, et al |
---|---|
Format: | article |
Language: | EN |
Published: |
Dove Medical Press
2011
|
Subjects: | |
Online Access: | https://doaj.org/article/36b5e466ed7f4db5b9ccd890eec48990 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Role of aripiprazole in treatment-resistant schizophrenia
by: Mossaheb N, et al.
Published: (2012) -
Pharmacotherapy of panic disorder
by: Charles B Pull, et al.
Published: (2008) -
Measurement of treatment adherence with antipsychotic agents in patients with schizophrenia
by: Xinhua S Ren, et al.
Published: (2009) -
Suicide risk in depression and bipolar disorder: Do impulsiveness-aggressiveness and pharmacotherapy predict suicidal intent?
by: Maurizio Pompili, et al.
Published: (2008) -
Double-blind comparison of ziprasidone and risperidone in the treatment of Chinese patients with acute exacerbation of schizophrenia
by: Hongyan Zhang, et al.
Published: (2011)